Abstract
To date, the algorithm for the treatment of recurrent ovarian cancer and the criteria for selecting patients for performing secondary cytoreductive surgeries have not been fully developed. Although the role of secondary surgery in recurrent ovarian cancer remains controversial, most retrospective studies showed better survival in patients for whom maximal cytoreduction was achieved. Several studies have developed prognostic models for the feasibility of performing complete secondary cytoreduction. We report a rare case of repeated cytoreductive surgeries in combination with chemotherapy for recurrent ovarian cancer. This clinical case indicates the feasibility of performing repeated cytoreductive surgeries in patients with localized recurrent ovarian cancer undergoing previous optimal cytoreductions and having no ascites.
Highlights
We report a rare case of repeated cytoreductive surgeries in combination with chemotherapy for recurrent ovarian cancer
This clinical case indicates the feasibility of performing repeated cytoreductive surgeries in patients with localized recurrent ovarian cancer undergoing previous optimal cytoreductions and having no ascites
Клинический пример показывает целесообразность повторных циторедуктивных операций в сочетании с химиотерапией при лечении рецидива рака яичников, в том числе у пациенток с наличием мутации BRCA при условии удовлетворительного состояния пациентки, оптимального характера предыдущей циторедуктивной операции, локальной формы рецидива, отсутствия асцита и незначительного повышения опухолевых маркеров
Summary
Для цитирования: Молчанов С.В., Коломиец Л.А., Шпилева О.В. Возможности повторных оптимальных циторедуктивных операций в комбинированном лечении рака яичников. For citation: Molchanov S.V., Kolomiets L.А., Shpilyeva О.V. Repeated optimal cytoreductive surgeries in combined modality treatment of ovarian cancer.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have